Loading clinical trials...
Loading clinical trials...
This study will investigate the safety of three fixed dose levels of tanezumab (2.5 mg, 5 mg, and 10 mg) administered at an 8-week interval by subcutaneous injection multiple (7) times during the stud...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT05986292 · Osteoarthritis, Knee, Diabetic Neuropathic Pain, and more
NCT06234631 · Knee Replacement Surgery, Osteoarthritis, Knee
NCT07069179 · Osteoarthritis, Osteoarthritis (OA) of the Knee, and more
NCT07364578 · Osteoarthritis, Knee
NCT06488144 · Osteoarthritis, Knee
Mobile Diagnostic Center
Mobile, Alabama
Seton Medical Management, Inc.
Mobile, Alabama
Phoenix Rheumatology Specialists, Ltd.
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions